HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast.

Saved in:
Bibliographic Details
Title: HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast.
Authors: Bièche I; Genetics Department, Institut Curie, University of Paris, Paris, France.; Department of Diagnostic and Theranostic Medicine Paris, University of Paris, Paris, France.; INSERM U1016, Institut Cochin, Paris, France., Coussy F; Medical Oncology Department, Institut Curie, PSL Research University, Paris, France., El-Botty R; Translational Research Department, Institut Curie, PSL Research University, 26 Rue d'Ulm, 75005, Paris, France., Vacher S; Genetics Department, Institut Curie, University of Paris, Paris, France.; Department of Diagnostic and Theranostic Medicine Paris, University of Paris, Paris, France., Château-Joubert S; BioPôle Alfort, Ecole Nationale Vétérinaire d'Alfort, Maisons Alfort, France., Dahmani A; Translational Research Department, Institut Curie, PSL Research University, 26 Rue d'Ulm, 75005, Paris, France., Montaudon E; Translational Research Department, Institut Curie, PSL Research University, 26 Rue d'Ulm, 75005, Paris, France., Reyes C; Translational Research Department, Institut Curie, PSL Research University, 26 Rue d'Ulm, 75005, Paris, France., Gentien D; Translational Research Department, Institut Curie, PSL Research University, 26 Rue d'Ulm, 75005, Paris, France., Reyal F; Surgery Department, Institut Curie, PSL Research University, Paris, France.; INSERM U932, Immunity and Cancer, Institut Curie, Paris, France., Ricci F; Medical Oncology Department, Institut Curie, PSL Research University, Paris, France., Nicolas A; Pathex, Institut Curie, PSL Research University, Paris, France., Marchio C; Institut Curie, Pathology Department, PSL Research University, Paris, France.; Pathology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Medical Sciences, University of Turin, Turin, Italy., Vincent-Salomon A; Institut Curie, Pathology Department, PSL Research University, Paris, France., Laé M; Pathology Department, Centre Henri Becquerel, INSERM U1245, Université Rouen Normandie, Rouen, France., Marangoni E; Translational Research Department, Institut Curie, PSL Research University, 26 Rue d'Ulm, 75005, Paris, France. elisabetta.marangoni@curie.fr.
Source: Journal of hematology & oncology [J Hematol Oncol] 2021 Sep 08; Vol. 14 (1), pp. 143. Date of Electronic Publication: 2021 Sep 08.
Publication Type: Letter; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1756-8722
DOI:10.1186/s13045-021-01158-3